Objective: Extracellular ATP mediates mast cell-dependent intestinal inflammation via P2X7 purinoceptors. We have previously shown that CD300f (also called the leucocyte mono-immunoglobulin-like receptor 3 (LMIR3)) suppresses immunoglobulin E-dependent and mast cell-dependent allergic responses by binding to ceramide. The aim of the present study was to clarify the role of ceramide–LMIR3 interaction in the development of IBD. Design: The dextran sodium sulfate (DSS)-induced colitis model was used in wild-type (WT),
LMIR3
−/− , mast cell-deficient
Kit
W-sh/W-sh ,
Kit
W-sh/W-sh
LMIR3
−/− or
Kit
W-sh/W-sh mice engrafted with WT or
LMIR3
−/− bone marrow-derived mast cells (BMMCs). The severity of colitis was determined by clinical and histological criteria. Lamina propria cell populations were assessed by flow cytometry. Production of chemical mediators from lamina propria cells was measured by real-time reverse transcription PCR. Production of chemical mediators from ATP-stimulated BMMCs in the presence or absence of ceramide was measured by ELISA. The severity of DSS-induced colitis was assessed in mice given either an Fc fusion protein containing an extracellular domain of LMIR3, and anticeramide antibody, or ceramide liposomes. Results: LMIR3 deficiency exacerbated DSS-induced colitis in mice.
Kit
W-sh/W-sh mice harbouring
LMIR3
−/− mast cells exhibited more severe colitis than those harbouring WT mast cells. Ceramide–LMIR3 interaction inhibited ATP-stimulated activation of BMMCs. DSS-induced colitis was aggravated by disrupting the ceramide–LMIR3 interaction, whereas it was suppressed by treating with ceramide liposomes. Conclusions: LMIR3-deficient colonic mast cells were pivotal in the exacerbation of DSS-induced colitis in
LMIR3
−/− mice. Ceramide liposomes attenuated DSS-induced colitis by inhibiting ATP-mediated activation of colonic mast cells through ceraimide–LMIR3 binding.
1 January 2014 in Journal of Allergy and Clinical Immunology
Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is a rare autoimmune disorder caused by neutralizing anti-ADAMTS13 autoantibodies. In Caucasians, human leukocyte antigen (HLA) allele DRB1*11 was a predisposing factor for iTTP, while DRB1*04 was a protective factor. However, the role of HLA in Asians is unclear. In this study, we analyzed 10 HLA loci using next-generation sequencing (NGS) in 52 Japanese patients with iTTP, and the allele frequency in the iTTP group was compared to that in a Japanese control group. We identified the following HLA alleles as predisposing factors for iTTP in the Japanese population: DRB1*08:03 (odds ratio [OR]: 3.06, corrected P-values [Pc]=0.005), DRB3/4/5*blank (OR: 2.3, Pc=0.007), DQA1*01:03 (OR: 2.25, Pc=0.006), and DQB1*06:01 (OR: 2.41, Pc=0.003). The estimated haplotype consisting of these 4 alleles was significantly more frequent in the iTTP group than in the control group (30.8% vs. 6.0%, Pc<0.001). DRB1*15:01 and DRB5*01:01 were weak protective factors for iTTP (OR 0.23, Pc=0.076; and OR 0.23, Pc=0.034, respectively). On the other hand, DRB1*11 and DRB1*04 were not associated with iTTP in Japanese. These findings indicated that predisposing and protective factors for iTTP differ between Japanese and Caucasians. HLA-DR molecules encoded by DRB1*08:03 and DRB1*11:01 have different peptide-binding motifs, but interestingly, were capable of binding to the shared ADAMTS13 peptide in an in silico prediction model.